Gliomatosis cerebri epidemiology and demographics: Difference between revisions
| Line 18: | Line 18: | ||
===Incidence=== | ===Incidence=== | ||
*The incidence | *The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.<ref>{{Cite web|url=https://www.ncbi.nlm.nih.gov/pubmed/29464663|title=Incidence and survival of gliomatosis cerebri: a population-based cancer registration study|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 03:13, 17 September 2019
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri epidemiology and demographics |
|
Gliomatosis cerebri epidemiology and demographics in the news |
|
Risk calculators and risk factors for Gliomatosis cerebri epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1] Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2] The median age at diagnosis is 34 years.[3] Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.[2]
Epidemiology and Demographics
Incidence
- Gliomatosis cerebri is a rare brain tumor. The incidence of gliomatosis cerebri is estimated to be less than 100 cases per year in the United States.[1]
Age
- Gliomatosis cerebri is a disease that tends to affect the middle-aged population. The peak incidence for gliomatosis cerebri is 20-40 years.[2]
- The median age at diagnosis is 34 years.[3]
Gender
- Males are more commonly affected with gliomatosis cerebri than females. The male to female ratio is approximately 1.5 to 1.[2]
Incidence
- The annual incidence rate of gliomatosis cerebri is approximately 0.1 per 1,000,000 individuals worldwide.[4]
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ 1.0 1.1 Gliomatosis cerebri international registry. http://gcregistry.com/
- ↑ 2.0 2.1 2.2 2.3 Epidemiology of gliomatosis cerebri. Dr Henry Knipe and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/gliomatosis-cerebri
- ↑ 3.0 3.1 Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH; et al. (1998). "Gliomatosis cerebri: clinical features, treatment, and prognosis". Acta Neurochir (Wien). 140 (8): 755–62. PMID 9810441.
- ↑ "Incidence and survival of gliomatosis cerebri: a population-based cancer registration study".